Detection Kit for the Novel Coronavirus Antibodies Developed by Jilin Province Enters Clinical Trial Stage

Rapid detection kit for the novel coronavirus IgG/IgM antibodies developed by Jilin province has been clinically evaluated by relevant medical institutions. Now it is actively applying for approval through the emergency approval green channel of the National Medical Products Administration. 
Initial findings are collected through the cooperation with clinical detection research. The operation of this detection method is simple and rapid with accurate results. The method also has less restrictions on detection personnel and workplace, complements nucleic acid detection, shortens the detection time of the novel coronavirus, accelerates the diagnosis of suspected cases and the on-site screening of close contacts. 
Recently, Jilin Provincial Science and Technology Department has recommended this rapid detection product to the Ministry of Science and Technology and applied for the emergency project of on-site rapid detection product development.